Abstract
Rheumatoid arthritis (RA), characterized by inflammation of the synovium and surrounding structures, has a prevalence of 0.5–1%. Rheumatoid vasculitis (RV) is an inflammatory condition of the small- and medium-sized vessels that affects up to 5% of patients with RA with intestinal involvement in 10–38% of these cases. Clinically apparent RV of the gastrointestinal (GI) tract, while rare, is often catastrophic, resulting in ischemic ulcers and bowel infarction. Vasculitis of the colon may present as pancolitis clinically similar to ulcerative colitis. Rectal biopsies that include submucosal vessels are positive for vasculitis in up to 40% of cases. Abnormal esophageal motility in RA may result in heartburn and dysphagia. Chronic atrophic gastritis may be associated with hypergastrinemia and hypo- or achlorhydria, promoting small bowel bacterial overgrowth. RA is the most common cause of secondary amyloidosis with GI symptoms in 22% of affected patients. Although amyloid is usually found in the liver, it is rarely evident clinically. Felty’s syndrome occurs in less than 1% of patients with RA and is characterized by neutropenia and splenomegaly. The liver may be involved with portal fibrosis or nodular regenerative hyperplasia. Liver histology is abnormal in 92% of RA patients at autopsy, although the changes are usually mild without associated hepatomegaly. Drug-induced liver disease may occur with aspirin, sulfasalazine, and methotrexate. Significant liver damage is rare if the drug is discontinued or the patient is properly monitored. RA can affect both the GI tract and the liver; changes are usually mild except with RV.
Similar content being viewed by others
References
Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmune Rev. 2005;4:130–136.
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthr Rheum. 2010;62:2569–2581.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum. 1988;31:315–324.
Suzuki A, Ohosone Y, Obana M, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994;21:33–36.
Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthr Rheum. 2006;36:88–98.
Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine. 1981;60:288–297.
Geirsson AJ, Sturfelt G, Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis. 1987;46:727–733.
Watts RA, Mooney J, Lane SE, Scott DG. Rheumatoid vasculitis: becoming extinct? Rheumatology. 2004;43:920–923.
Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthr Rheum. 1996;39:732–735.
Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JMW. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis. 1996;55:190–192.
Lindsay MK, Tavadia HB, Whyte AS, Lee P, Webb J. Acute abdomen in rheumatoid arthritis due to necrotizing arteritis. Br Med J. 1973;2:592–593.
Bienenstock H, Minick CR, Rogof B. Mesenteric arteritis and intestinal infarction in rheumatoid disease. Arch Intern Med. 1967;119:359–364.
Babian M, Nasef S, Soloway G. Gastrointestinal infarction as a manifestation of rheumatoid vasculitis. Am J Gastroenterol. 1998;93:119–120.
Achkar AA, Stanson AW, Johnson M, et al. Rheumatoid vasculitis manifesting as intra-abdominal hemorrhage. Mayo Clin Proc. 1995;70:565–569.
Van Laar JM, Smit VT, de Beus WM, Collee G, Jansen EH, Breedveld FC. Rheumatoid vasculitis presenting as appendicitis. Clin Exp Rheumatol. 1998;16:736–738.
Kuehne SE, Gauvin GP, Shortsleeve MJ. Small bowel stricture caused by rheumatoid vasculitis. Radiology. 1992;184:215–216.
Mizuno K, Ikeda K, Saida Y, Takenaka R, Shibata M, Takeuchi T. Hepatic hemorrhage in malignant rheumatoid arthritis. Am J Gastroenterol. 1996;91:2624–2625.
Hocking WG, Lasser K, Ungerer R, Bersohn M, Palos M, Spiegel T. Spontaneous hepatic rupture in rheumatoid arthritis. Arch Intern Med. 1981;141:792–794.
Dahlberg PJ, Lockhart JM, Overholt EL. Diagnostic studies for systemic necrotizing vasculitis. Sensitivity, specificity, and predictive value in patients with multisystem disease. Arch Intern Med. 1989;149:161–165.
Tribe CR, Scott DGI, Bacon PA. Rectal biopsy in the diagnosis of systemic vasculitis. J Clin Pathol. 1981;34:843–850.
Warren CPM. Arthritis associated with salmonella infections. Ann Rheum Dis. 1970;29:483–487.
Berden JH, Muyntjens HL, Van de Putte LB. Reactive arthritis associated with Campylobacter jejuni enteritis. Br Med J. 1976;i:380–381.
Drenick EJ, Bassett LW, Stanley TM. Rheumatoid arthritis associated with jejunoileal bypass. Arthr Rheum. 1984;27:1300–1305.
Bjarnason I, Williams P, So A, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of nonsteroidal anti-inflammatory drugs. Lancet. 1984;ii:1171–1174.
Segal AW, Isenberg DA, Hajiprouso V, Tolfree S, Clark J, et al. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis? Br J Rheumatol. 1986;25:162–166.
Podas T, Nightingale JMD, Oldham R, Roy S, Sheehan NJ, Mayberry JF. Is rheumatoid arthritis a disease that starts in the intestine? A pilot study comparing an elemental diet with oral prednisolone. Postgrad Med J. 2007;83:128–131.
Marcolongo R, Bayeli PF, Montagnani M. Gastrointestinal involvement in rheumatoid arthritis: a biopsy study. J Rheum. 1979;6:163–173.
Bjarnason I, Hopkinson H, Zanelli G, Prouse P, Smethurst P, et al. Treatment of non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1990;31:777–780.
O’Farrelly C, Marten D, Melcher D, et al. Association between villous atrophy in rheumatoid arthritis and a rheumatoid factor and gliadin-specific IgG. Lancet. 1988;ii:819–822.
Francis J, Carty JE, Scott BB. The prevalence of celiac disease in rheumatoid arthritis. Eur J Gastroenterol Hepatol. 2002;14:1355–1356.
Hvatum M, Kanerud L, Hallgren R, Brandtzaeg P. The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis. Gut. 2006;55:1240–1247.
Pillemer SR, Reynolds WJ, Yoon SJ, Perera M, Newkirk M, Klein M. IgA related disorders in rheumatoid arthritis. J Rheumatol. 1987;14:880–886.
Teitsson I, Withrington RH, Seifert MH, Valdimarsson H. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis. 1984;43:673–678.
Ludviksson BR, Jonsson T, Erlendsson K, Sigfusson A. Disease manifestations in patients with isolated elevation of IgA rheumatoid factor. Scand J Rheumatol. 1992;21:1–4.
Kanerud L, Engstrom GN, Tarkowski A. Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis. Ann Rheum Dis. 1995;54:256–262.
Franks AST. Temporomandibular joint in adult rheumatoid arthritis. A comparative evaluation of 100 cases. Ann Rheum Dis. 1969;28:139–145.
Lindquist C, Santavirta S, Sandelin J, et al. Dysphagia and micrognathia in a patient with juvenile rheumatoid arthritis. Clin Rheumatol. 1986;5:410–415.
Sun DCH, Roth SH, Mitchell CS, England DW. Upper gastrointestinal disease in rheumatoid arthritis. Dig Dis Sci. 1974;19:405–410.
John V, Stirling AJ, Matthews HR. Rheumatoid stricture of oesophagus. Br Med J. 1978;1:479.
Malone ED, McCormick PA, Daly L, et al. Peptic ulcer in rheumatoid arthritis—intrinsic or related to drug therapy? Br J Rheumatol. 1986;25:342–344.
Goggins PM, Collins DA, Jazrawi RP, et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut. 1993;34:1677–1680.
Doube A, Collins AJ. Editorial: is the gut intrinsically abnormal in rheumatoid arthritis? Ann Rheum Dis. 1988;47:617–619.
Henriksson AEK, Blomquist L, Nord CE, Midtvedt T, Uribe A. Small intestinal bacterial overgrowth in patients with rheumatoid arthritis. Ann Rheum Dis. 1993;52:503–510.
De Witte TJ, Geerdink PJ, Lamers CB, Boerbooms AM, van der Korst JK. Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis. Ann Rheum Dis. 1979;38:14–17.
Rowden DR, Taylor IL, Richter JA, Pinals RS, Levine RA. Is hypergastrinaemia associated with rheumatoid arthritis? Gut. 1978;19:1064–1067.
Rooney PJ, Vince J, Kennedy AC, Webb J, Lee P, et al. Hypergastrinaemia in rheumatoid arthritis: disease or iatrogenesis. Br Med J. 1973;1:752–753.
Rooney PJ, Kennedy AC, Gray GH, Sturrock RD, Buchanan KD, Dick WC. Serum immunoreactive gastrin in rheumatoid arthritis. Ann Rheum Dis. 1976;35:246–250.
Henriksson K, Uvnas-Moberg K, Nord CE, Johansson C, Gullberg R. Gastrin, gastric acid secretion, and gastric microflora in patients with rheumatoid arthritis. Ann Rheum Dis. 1986;45:475–483.
Partridge REH, Duthie JJR. Incidence of macrocytic anaemia in rheumatoid arthritis. Br Med J. 1963;1:89–91.
Snook JA, De Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease. Quart J Med. 1989;72:835–840.
Adachi Y, Hinoda Y, Takahashi H, et al. Rheumatoid arthritis associated with ulcerative colitis. J Gastroenterol. 1996;31:590–595.
Toussirot E, Wendling D. Crohn’s disease associated with seropositive rheumatoid arthritis. Clin Exp Rheumatol. 1997;15:307–311.
Burt RW, Berenson MM, Samuelson CO, et al. Rheumatoid vasculitis of the colon presenting as pancolitis. Dig Dis Sci. 1983;28:183–188.
Ryutaro M, Masaru M, Tetsuya T, Yoshiro O, Ken Y, Tetsuo A. A case of pneumatosis cystoides intestinalis associated with rheumatoid arthritis, Sjögren’s syndrome, and abdominal free air. J Jpn Surg Assoc. 2004;65(5):1285–1289.
Seaman WE, Plotz PH, Ishak KG. Aspirin-induced hepatotoxicity in patients with RA or systemic lupus erythematosus (SLE). Arthr Rheum. 1974;17:325.
Rich RR, Johnson JS. Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthr Rheum. 1973;16(1):1–9.
Miller JJ, Weissman DB. Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis. Arthr Rheum. 1976;19:115–118.
Athreya BH, Moser G, Cecil HS, Myers AR. Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis. A prospective study. Arthr Rheum. 1975;18:347–352.
Bernstein BH, Singsen BH, King KK, Hanson V. Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis. Am J Dis Child. 1977;131:659–663.
Caspi D, Fuchs D, Yaron M. Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis. Ann Rheum Dis. 1992;51:275–276.
Losek JD, Werlin SL. Sulfasalazine hepatotoxicity. Am J Dis Child. 1981;135:1070–1071.
West SG. Methotrexate hepatotoxicity. Rheum Dis Clin North Am. 1997;23:883–915.
Kremer JM, Alarcon GS, Lightfoot RW, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Am College Rheumatol Arthr Rheum. 1994;37(3):316–328.
Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine. 1991;70:246–256.
Kuroda T, Tanabe N, Sakatsume M, et al. Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin Rheum. 2002;21:123–128.
Kobayashi H, Tada S, Fuchigami T, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol. 1996;35:44–49.
Fushimi T, Takahashi Y, Kashima Y, et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid. 2005;12:48–53.
Babb RB, Alarcon-Segovia D, Dressner GR, McPherson JR. Malabsorption in rheumatoid arthritis: an increased complication caused by amyloidosis. Arthr Rheum. 1967;10:63–70.
Pettersson T, Wegelius O. Biopsy diagnosis of amyloidosis in rheumatoid arthritis. Malabsorption caused by intestinal amyloid deposits. Gastroenterology. 1972;62:22–27.
Shimada Y, Tosa H, Terasawa K, Tanaka M. A gastrointestinal endoscopic study on secondary amyloidosis complicating rheumatoid arthritis. Dig Endosc. 1992;4:37–42.
Klem PJ, Sorsa S, Happonen RP. Fine-needle aspiration biopsy from subcutaneous fat: an easy way to diagnose secondary amyloidosis. Scand J Rheumatol. 1987;16:429–431.
Oishi K, Wada J, Nagake Y, et al. Fatal pancreatitis associated with systemic amyloidosis in a rheumatoid arthritis patient. J Med. 2000;31:303–310.
Shimoyama M, Ohtahara A, Fukui H, et al. Acute secondary gastrointestinal amyloidosis in a patient with rheumatoid arthritis. Am J Med Sci. 2003;326(3):145–147.
Kuroda T, Otaki Y, Sato H, et al. A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with infliximab. Rheumatol Int. 2008;28:1155–1159.
Sienknecht CW, Urowitz MB, Pruzanski W, Stein HB. Felty’s syndrome: clinical and serological analysis of 34 cases. Ann Rheum Dis. 1977;36:500–507.
Thorne C, Urowitz MB, Wanless I, Roberts E, Blendis LM. Liver disease in Felty’s syndrome. Am J Med. 1982;73:35–40.
Cohen ML, Manier JW, Bredfeldt JE. Sinusoidal lymphocytosis of the liver in Felty’s syndrome with a review of the liver involvement in Felty’s syndrome. J Clin Gastroenterol. 1989;11:92–94.
Blendis LM, Ansell ID, Jones KL, Hamilton E, Williams R. Liver in Felty’s syndrome. Br Med J. 1970;1:131–135.
Cohen MD, Ginsburg WW, Allen GL. Nodular regenerative hyperplasia of the liver and bleeding esophageal varices in Felty’s syndrome. A case report and literature review. J Rheumatol. 1982;9:716–718.
Tiger LH, Gordon MH, Erhlich GE, Shapiro B. Liver enlargement demonstrated by scintigraphy in rheumatoid arthritis. J Rheumatol. 1976;3:15–20.
Schaller J, Beckwith B, Wedgwood RJ. Hepatic involvement in juvenile rheumatoid arthritis. J Pediatrics. 1970;77:203–210.
Haskard DO, Higgins CS, Temple LN, Currey HLF. Spontaneous rupture of the spleen in rheumatoid arthritis. Ann Rheum Dis. 1983;42:4111–4114.
Cockel R, Kendall MJ, Becher JF, Hawkins CF. Serum biochemical values in rheumatoid disease. Ann Rheum Dis. 1971;30:166–170.
Rau R, Pfenninger K, Boni A. Liver function tests and liver biopsies in patients with rheumatoid arthritis. Ann Rheum Dis. 1975;34:198–199.
Fernandes L, Sullivan S, McFarlane IG, et al. Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis. Ann Rheum Dis. 1979;38:501–506.
Spooner RJ, Smith DH, Bedford D, Beck PR. Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis. J Clin Pathol. 1983;35:638–641.
Akesson A, Berglund K, Karlsson M. Liver function in some common rheumatic diseases. Scand J Rheumatol. 1980;9:81–88.
Webb J, Whaley K, MacSween RNM, Nuki G, Dick WC, Buchanan WW. Liver disease in rheumatoid arthritis and Sjögren’s syndrome. Ann Rheum Dis. 1975;34:70–81.
Aida S. Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity. Ann Rheum Dis. 1993;52:511–516.
Kendall MJ, Cockel R, Becker J, Hawkins CF. Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction? Ann Rheum Dis. 1980;29:537–540.
Nanke Y, Kotake S, Akama H, Kamatani N. Alkaline phosphatase in rheumatoid arthritis patients: possible contribution of bone-type ALP to the raised activities of ALP in rheumatoid arthritis patients. Clin Rheumatol. 2002;21:198–202.
Kendall MJ, Farr M, Bold AM, Hawkins CF. 5′-nucleotidase in the serum and synovial fluid of patients with rheumatoid disease. Lancet. 1971;2:1012–1013.
Lowe JR, Pickup ME, Dixon JS, et al. Gamma glutamyl transpeptidase levels in arthritis: a correlation with clinical and laboratory indices of disease activity. Ann Rheum Dis. 1978;37:428–431.
Thompson PW, Houghton BJ, Clifford C, Jones DD, Whitaker KB, Moss DW. Source and significance of raised serum enzymes in rheumatoid arthritis. Quart J Med. 1990;76:869–879.
Whaley K, Williamson J, Goudie RB, Nuki G, Buchanan WW. Liver disease in Sjögren’s syndrome and rheumatoid arthritis. Lancet. 1970;1:861–863.
Kantharia BK, Woolf AD. Raised alkaline phosphatase in rheumatoid arthritis: primary biliary cirrhosis? Br J Rheumatol. 1987;26:313–314.
Gow PJ, Fleming KA, Chapman RW. Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease? J Hepatol. 2000;34:631–635.
Ruderman EM, Crawford JM, Maier A, Liu JJ, Gravallese EM, Weinblatt ME. Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis. Br J Rheumatol. 1997;36:210–213.
Leftkovits AM, Farrow U. The liver in rheumatoid arthritis. Ann Rheum Dis. 1955;14:162–168.
Laffon A, Moreno A, Gutierrez-Bucero A, Ossorio C, Sabando P, Moreno-Otero R. Hepatic sinusoidal dilatation in rheumatoid arthritis. J Clin Gastroenterol. 1989;11(6):653–657.
Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21:613–619.
Buskila D. Hepatitis C associated arthritis. Curr Opin Rheumatol. 2000;12:295–299.
Sene D, Ghillani-Dalbin P, Limal N, et al. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren’s syndrome. Ann Rheum Dis. 2006;65:394–397.
Morris EL, Stevens MB. Rheumatoid arthritis—a sequel to HBsAg hepatitis. Am J Med. 1978;64:859–862.
Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis after chronic hepatitis caused by hepatitis C virus infection. Intern Med. 1992;31:493–495.
Peterson JR, Hsu FC, Simkin PA, Wener MH. Effect of tumor necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis. 2003;62:1078–1082.
Zein NN. Etanercept as an adjuvant to interferon and ribavirin in treatment-naïve patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol. 2005;42:315–322.
Nathan DM, Angus PW. Gibson PR: hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach. J Gastroenterol Hepatol. 2006;21:1366–1371.
Takahashi A, Yokokawa J, Iwadate H, et al. Clinical features of liver dysfunction in collagen diseases. Hepatol Res. 2010;40(11):1092–1097.
Kojima H, Uemura M, Sakurai S, et al. Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance. J Gastroenterol. 2002;37:617–625.
Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology. 1993;18:998–1005.
Conflict of interest
The authors have no financial interests to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ebert, E.C., Hagspiel, K.D. Gastrointestinal and Hepatic Manifestations of Rheumatoid Arthritis. Dig Dis Sci 56, 295–302 (2011). https://doi.org/10.1007/s10620-010-1508-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1508-7